Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge is advising Acrinova in its rights issue
Mandate

Vinge is advising Acrinova in its rights issue

May 07, 2021 Capital Markets and Public M&A

Vinge is advising Acrinova AB (publ) in connection with a rights issue which will provide Acrinova with issue proceeds amounting to a maximum of SEK 130 million.

Acrinova is an entrepreneurial-run real estate company operating in southern Sweden with a focus on the Öresund region. Acrinova’s property portfolio is developed through acquisitions, project development and refinement.

Acrinova is listed on Nasdaq First North Growth Market.

Vinge’s team consisted of Linnéa Sellström, Julia Hirschberg and Lorin Arabi.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025